Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Consider benefits and risks of new alopecia treatments for safety.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

The study identified the top 10 most important areas for future hair loss research.

Yellow dots and short vellus hairs are key signs for diagnosing alopecia areata using trichoscopy.

New cytokine-targeted therapies show promise for treating alopecia areata.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Non-invasive methods can effectively diagnose and manage alopecia areata.

We need better research to improve alopecia treatment and patient care.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

The woman's hair loss pattern doesn't match typical conditions like alopecia areata or female pattern hair loss.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Loss of oil glands and inflammation might contribute to the development of scarring hair loss.

A simple scalp scraping can effectively distinguish fibrosing alopecia from androgenetic alopecia with seborrheic dermatitis.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Hydroxychloroquine is ineffective for treating frontal fibrosing alopecia with lupus erythematosus.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Antimicrobial therapy can help manage Folliculitis Decalvans.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.